US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

42.47

+0.33000.78%

Post-market: 42.470.00000.00%19:30 EDT

Volume:531.64K

Turnover:22.39M

Market Cap:1.37B

PE:-14.21

High:42.54

Open:42.22

Low:41.39

Close:42.14

52wk High:50.16

52wk Low:13.36

Shares:32.26M

Float Shares:21.62M

Volume Ratio:2.02

T/O Rate:2.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9880

EPS(LYR):-3.1329

ROE:-50.00%

ROA:-29.98%

PB:4.12

PE(LYR):-13.56

Loading ...

Overview Company News Filings

Lb Pharmaceuticals Inc Q2 Basic EPS USD -1.71

THOMSON REUTERS

Lb Pharmaceuticals Inc Q2 Pretax Profit USD -51.603 Million

THOMSON REUTERS

Press Release: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

LB Pharmaceuticals management to meet with Piper Sandler

LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.

LB Pharmaceuticals Prices USD 150 Million Private Placement at USD 34.94 Per Share

Lb Pharmaceuticals - Net Proceeds to Fund Lb-102 Pipeline Expansion and General Corporate Purposes

THOMSON REUTERS

Lb Pharmaceuticals Announces $150 Million Private Placement

THOMSON REUTERS

LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained

LB Pharmaceuticals Releases Update on Nova-2 Phase 3 Schizophrenia Trial Timeline

Lb Pharmaceuticals - Topline Data from Phase 2 Trial in Adjunctive Mdd Expected in H1 2029

THOMSON REUTERS

Lb Pharmaceuticals - Expects Cash Runway into Q2 2029

THOMSON REUTERS

Lb Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 Nova-2 Trial of Lb-102 in Schizophrenia

THOMSON REUTERS

Lb Pharmaceuticals - to Report Phase 3 Nova-2 Topline Results in H1 2027

THOMSON REUTERS

Lb Pharmaceuticals - Topline Data from Phase 2 Illuminate-1 in Bipolar Depression Expected in Q1 2028

THOMSON REUTERS

Lb Pharmaceuticals Inc : Bmo Initiates Coverage with Outperform Rating; Target Price $46

THOMSON REUTERS

LB Pharmaceuticals Initiated at Outperform by BMO Capital

LB Pharmaceuticals Grants SVP Zergebel Option for 75,000 Shares at $32.95 Under NASDAQ Inducement Rule

Lb Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LBRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals","latestPrice":42.47,"timestamp":1789761600000,"preClose":42.14,"halted":0,"volume":531641,"hourTrading":{"tag":"盘后","latestPrice":42.47,"preClose":42.47,"latestTime":"19:30 EDT","volume":45602,"amount":1936689.6436,"timestamp":1789774206084,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007831039392501146,"floatShares":21621800,"shares":32259175,"eps":-2.988,"marketStatus":"Market Closed","change":0.33,"latestTime":"09-18 16:00:00 EDT","open":42.22,"high":42.54,"low":41.385,"amount":22390779.493632,"amplitude":0.027409,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.988,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":42.14,"preHourTrading":{"tag":"盘前","latestPrice":43,"preClose":42.14,"latestTime":"07:51 EDT","volume":60,"amount":2580.34998,"timestamp":1789732272090,"change":0.86,"changeRate":0.020408,"amplitude":0.008306},"postHourTrading":{"tag":"盘后","latestPrice":42.47,"preClose":42.47,"latestTime":"19:30 EDT","volume":45602,"amount":1936689.6436,"timestamp":1789774206084,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.016661,"impliedVol":1.2006,"impliedVolPercentile":0.9872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":21621800,"roa":"-29.98%","roe":"-50.00%","lyrEps":-3.132945,"volumeRatio":2.016661,"shares":32259175,"dividePrice":0,"high":42.54,"amplitude":0.027409,"preClose":42.14,"low":41.385,"week52Low":13.36,"pbRate":"4.12","week52High":50.16,"institutionHeld":0,"latestPrice":42.47,"eps":-2.988,"divideRate":0,"volume":531641,"delay":0,"ttmEps":-2.988,"open":42.22,"prevYearClose":22.26,"prevWeekClose":44.63,"prevMonthClose":47.26,"prevQuarterClose":32.455,"fiveDayClose":44.63,"twentyDayClose":47.23,"sixtyDayClose":30.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.71},{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-09-17","current":-14.213521,"percent":0.834646,"low":-37.407457,"twenty":-31.853943,"median":-23.934856,"eighty":-17.432378,"high":-0.410019,"avg":-23.872295,"sd":7.506025,"marketCap":1373273079},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-15","current":-23.123601,"twenty":-32.316764,"median":-26.760218,"eighty":-12.583143,"marketCap":900733639},{"date":"2026-05-22","current":-20.613207,"twenty":-32.30331,"median":-26.667619,"eighty":-12.598395,"marketCap":802946256},{"date":"2026-05-29","current":-20.2672,"twenty":-32.30331,"median":-26.565134,"eighty":-12.6289,"marketCap":789468229},{"date":"2026-06-05","current":-21.275774,"twenty":-32.281784,"median":-26.235508,"eighty":-12.715838,"marketCap":828755242},{"date":"2026-06-12","current":-21.010748,"twenty":-32.254875,"median":-25.973152,"eighty":-12.741767,"marketCap":818431648},{"date":"2026-06-18","current":-22.122388,"twenty":-32.201059,"median":-25.758446,"eighty":-12.784474,"marketCap":861733392},{"date":"2026-06-26","current":-22.821765,"twenty":-32.168769,"median":-25.603165,"eighty":-13.037355,"marketCap":888976212},{"date":"2026-07-02","current":-23.476971,"twenty":-32.141861,"median":-25.394457,"eighty":-14.887526,"marketCap":914498432},{"date":"2026-07-10","current":-24.838915,"twenty":-32.079972,"median":-25.197689,"eighty":-17.661739,"marketCap":967550238},{"date":"2026-07-17","current":-22.519929,"twenty":-32.026155,"median":-24.876643,"eighty":-18.127213,"marketCap":877218784},{"date":"2026-07-24","current":-25.486758,"twenty":-31.993865,"median":-24.857779,"eighty":-18.396949,"marketCap":992785692},{"date":"2026-07-31","current":-30.110006,"twenty":-31.988483,"median":-25.029051,"eighty":-18.623718,"marketCap":1172875066},{"date":"2026-08-07","current":-35.46944,"twenty":-32.036919,"median":-25.243817,"eighty":-19.236335,"marketCap":1381641093},{"date":"2026-08-14","current":-16.667021,"twenty":-32.036919,"median":-25.197689,"eighty":-18.062763,"marketCap":1428113677},{"date":"2026-08-21","current":-17.781418,"twenty":-31.993865,"median":-24.876643,"eighty":-17.822455,"marketCap":1523600835},{"date":"2026-08-28","current":-18.029899,"twenty":-31.988483,"median":-24.686825,"eighty":-17.939919,"marketCap":1544891890},{"date":"2026-09-04","current":-17.890599,"twenty":-31.950812,"median":-24.595973,"eighty":-17.81229,"marketCap":1532955996},{"date":"2026-09-11","current":-17.412462,"twenty":-31.886233,"median":-24.257328,"eighty":-17.792713,"marketCap":1491986843},{"date":"2026-09-17","current":-16.026995,"twenty":-31.853943,"median":-23.934856,"eighty":-17.432378,"marketCap":1373273079}],"updateTime":1789770611465},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658997706","title":"Lb Pharmaceuticals Inc Q2 Basic EPS USD -1.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997706?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX2ZR14F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997047","title":"Lb Pharmaceuticals Inc Q2 Pretax Profit USD -51.603 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997047?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX2ZR14F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990834","title":"Press Release: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990834?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449600,"startTime":"0","endTime":"0","summary":"evaluating the efficacy and safety of LB-102 in patients with acute. Company expects to schedule a pre-NDA meeting with the FDA thereafter in. -- The 52-week open-label safety and tolerability trial , evaluating. the long-term safety and tolerability of LB-102 in patients with stable. schizophrenia, is enrolling eligible patients who have c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4233","LBRX","BK4007","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956102","title":"LB Pharmaceuticals management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956102?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:00","pubTimestamp":1786392021,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on August 17 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","BK4007","LBRX","LB","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656024378","title":"LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2656024378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656024378?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:42","pubTimestamp":1785753720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886045","title":"LB Pharmaceuticals Prices USD 150 Million Private Placement at USD 34.94 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886045","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886045?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:20","pubTimestamp":1785327655,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals prices USD 150 million private placement at USD 34.94 per shareLB Pharmaceuticals priced a USD 150 million private placement of common stock and pre-funded warrants with institution","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL74y1xn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655867089","title":"Lb Pharmaceuticals - Net Proceeds to Fund Lb-102 Pipeline Expansion and General Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2655867089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655867089?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA6VXJQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655290867","title":"Lb Pharmaceuticals Announces $150 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2655290867","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655290867?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA6VXJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653721485","title":"LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2653721485","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653721485?lang=en_us&edition=fundamental","pubTime":"2026-07-23 23:25","pubTimestamp":1784820335,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on LB Pharmaceuticals, Inc., with a price target of $45.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reaffirmed-on-lb-102-clinical-momentum-and-regulatory-progress-45-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reaffirmed-on-lb-102-clinical-momentum-and-regulatory-progress-45-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653875778","title":"LB Pharmaceuticals Releases Update on Nova-2 Phase 3 Schizophrenia Trial Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2653875778","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653875778?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:04","pubTimestamp":1784721878,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals releases update on NOVA-2 Phase 3 schizophrenia trial timelineLB Pharmaceuticals posted a press release accelerating expected topline timing for Phase 3 NOVA-2 data for LB-102 in sc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL7Nm80f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4585","BK4588","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014039.USD","LU2210150020.SGD","LBRX","BCDF","BK4007","SG9999014005.SGD","IE00BGHQF748.EUR","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757466","title":"Lb Pharmaceuticals - Topline Data from Phase 2 Trial in Adjunctive Mdd Expected in H1 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757466?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757457","title":"Lb Pharmaceuticals - Expects Cash Runway into Q2 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757457?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757430","title":"Lb Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 Nova-2 Trial of Lb-102 in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757430?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757102","title":"Lb Pharmaceuticals - to Report Phase 3 Nova-2 Topline Results in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757102?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653482757","title":"Lb Pharmaceuticals - Topline Data from Phase 2 Illuminate-1 in Bipolar Depression Expected in Q1 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2653482757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653482757?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653427942","title":"Lb Pharmaceuticals Inc : Bmo Initiates Coverage with Outperform Rating; Target Price $46","url":"https://stock-news.laohu8.com/highlight/detail?id=2653427942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653427942?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:49","pubTimestamp":1784630990,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653437273","title":"LB Pharmaceuticals Initiated at Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2653437273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653437273?lang=en_us&edition=fundamental","pubTime":"2026-07-21 17:43","pubTimestamp":1784626980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 05:43 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BMO","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137199","title":"LB Pharmaceuticals Grants SVP Zergebel Option for 75,000 Shares at $32.95 Under NASDAQ Inducement Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137199?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:39","pubTimestamp":1783715982,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals grants SVP Zergebel option for 75,000 shares at $32.95 under Nasdaq inducement ruleLB Pharmaceuticals granted new SVP Clinical Operations Christopher Zergebel a stock option for 75,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL21tbY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4007","BK4112","LBRX","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","BK4585","NDAQ","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BCDF","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137975","title":"Lb Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137975?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:38","pubTimestamp":1783715938,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nTUA9WQGXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137122","title":"Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137122?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:38","pubTimestamp":1783715880,"startTime":"0","endTime":"0","summary":"NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), today announced that it has granted to Christopher Zergebel, the new Senior V","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QYLG","QQQA","TECS","QQQJ","TQQY","JEPQ","BK4233","QQQE","IYW","QID","MNQmain","QLD","GPIQ","QQQY","SQQQ","PSQ","TQQQ",".IXIC","NQmain","LB","BK4007","QDTE","QQQM","BK4213","ONEQ","QQQ","NDX","NVIW.SI","LBRX","FTEC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":84,"code":"91000000","status":"200"}]}}